Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-03-16

Clinical Trial Update: Evaluation of Potential Effect of Artemether - Lumefantrine and Malaria Drugs on Auditory Function [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating potential auditory effects of artemether-lumefantrine and other malaria drugs; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artemether-lumefantrine (artemether and lumefantrine)

Snippet

Sponsor: Novartis | Conditions: Malaria, Falciparum | Phase 4 | Status: COMPLETED | Results posted: 2011-03-16